176 related articles for article (PubMed ID: 24412851)
1. Design, synthesis and docking studies of bischalcones based quinazoline-2(1H)-ones and quinazoline-2(1H)-thiones derivatives as novel inhibitors of cathepsin B and cathepsin H.
Raghav N; Singh M
Eur J Pharm Sci; 2014 Apr; 54():28-39. PubMed ID: 24412851
[TBL] [Abstract][Full Text] [Related]
2. 2,3-Dihydroquinazolin-4(1H)-one derivatives as potential non-peptidyl inhibitors of cathepsins B and H.
Singh M; Raghav N
Bioorg Chem; 2015 Apr; 59():12-22. PubMed ID: 25665518
[TBL] [Abstract][Full Text] [Related]
3. Quinazoline derivatives as cathepsins B, H and L inhibitors and cell proliferating agents.
Raghav N; Jangra S; Kumar A; Bhattacharyya S
Int J Biol Macromol; 2017 Jan; 94(Pt A):719-727. PubMed ID: 27780761
[TBL] [Abstract][Full Text] [Related]
4. SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H.
Raghav N; Singh M
Bioorg Med Chem; 2014 Aug; 22(15):4233-45. PubMed ID: 24913985
[TBL] [Abstract][Full Text] [Related]
5. 2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L.
Garg S; Raghav N
Bioorg Chem; 2016 Aug; 67():64-74. PubMed ID: 27285276
[TBL] [Abstract][Full Text] [Related]
6. SAR studies of o-hydroxychalcones and their cyclized analogs and study them as novel inhibitors of cathepsin B and cathepsin H.
Raghav N; Garg S
Eur J Pharm Sci; 2014 Aug; 60():55-63. PubMed ID: 24780403
[TBL] [Abstract][Full Text] [Related]
7. SAR studies of some acetophenone phenylhydrazone based pyrazole derivatives as anticathepsin agents.
Raghav N; Singh M
Bioorg Chem; 2017 Dec; 75():38-49. PubMed ID: 28915464
[TBL] [Abstract][Full Text] [Related]
8. Quinazolinones, Quinazolinthiones, and Quinazolinimines as Nitric Oxide Synthase Inhibitors: Synthetic Study and Biological Evaluation.
Camacho ME; Chayah M; García ME; Fernández-Sáez N; Arias F; Gallo MA; Carrión MD
Arch Pharm (Weinheim); 2016 Aug; 349(8):638-50. PubMed ID: 27328401
[TBL] [Abstract][Full Text] [Related]
9. N-formylpyrazolines and N-benzoylpyrazolines as novel inhibitors of mammalian cathepsin B and cathepsin H.
Raghav N; Garg S
Bioorg Chem; 2014 Dec; 57():43-50. PubMed ID: 25181676
[TBL] [Abstract][Full Text] [Related]
10. Acyl hydrazides and triazoles as novel inhibitors of mammalian cathepsin B and cathepsin H.
Raghav N; Singh M
Eur J Med Chem; 2014 Apr; 77():231-42. PubMed ID: 24642566
[TBL] [Abstract][Full Text] [Related]
11. Discovery and kinetic evaluation of 6-substituted 4-benzylthio-1,3,5-triazin-2(1H)-ones as inhibitors of cathepsin B.
Sosič I; Mirković B; Turk S; Štefaneb B; Kos J; Gobec S
Eur J Med Chem; 2011 Sep; 46(9):4648-56. PubMed ID: 21849222
[TBL] [Abstract][Full Text] [Related]
12. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.
Kim SH; Lee E; Baek KH; Kwon HB; Woo H; Lee ES; Kwon Y; Na Y
Bioorg Med Chem Lett; 2013 Jun; 23(11):3320-4. PubMed ID: 23608763
[TBL] [Abstract][Full Text] [Related]
13. [Design, synthesis and biological evaluation of novel para-substituted 1-benzyl-quinazoline-2, 4 (1H, 3H)-diones as human PARP-1 inhibitors].
Yao HP; Zhu ZX; Ji M; Chen XG; Xu BL
Yao Xue Xue Bao; 2014 Apr; 49(4):497-503. PubMed ID: 24974467
[TBL] [Abstract][Full Text] [Related]
14. Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase.
Cavalli A; Lizzi F; Bongarzone S; Brun R; Luise Krauth-Siegel R; Bolognesi ML
Bioorg Med Chem Lett; 2009 Jun; 19(11):3031-5. PubMed ID: 19414258
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological screening, and molecular docking of quinazolinone and quinazolinethione as phosphodiesterase 7 inhibitors.
Elfeky SM; Sobahi TR; Gineinah MM; Ahmed NS
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900211. PubMed ID: 31696968
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and interaction study of quinazoline-2(1H)-thione derivatives as novel potential Bcl-xL inhibitors.
Feng Y; Ding X; Chen T; Chen L; Liu F; Jia X; Luo X; Shen X; Chen K; Jiang H; Wang H; Liu H; Liu D
J Med Chem; 2010 May; 53(9):3465-79. PubMed ID: 20405848
[TBL] [Abstract][Full Text] [Related]
17. Chalcones, semicarbazones and pyrazolines as inhibitors of cathepsins B, H and L.
Raghav N; Kaur R
Int J Biol Macromol; 2015 Sep; 80():710-24. PubMed ID: 26193682
[TBL] [Abstract][Full Text] [Related]
18. Study on enhanced serum protein protecting and anti-cathepsin activities of various curcumin formulations containing traditional excipients and bio-enhancers.
Raghav N; Mor N
Bioorg Chem; 2020 Nov; 104():104177. PubMed ID: 32919129
[TBL] [Abstract][Full Text] [Related]
19. Some thiocarbamoyl based novel anticathepsin agents.
Kaur R; Raghav N
Bioorg Chem; 2020 Nov; 104():104174. PubMed ID: 32932119
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of thioether derivatives of quinazoline-4-one-2-thione and evaluation of their antiplatelet aggregation activity.
Eskandariyan Z; Esfahani Zadeh M; Haj Mohammad Ebrahim Tehrani K; Mashayekhi V; Kobarfard F
Arch Pharm Res; 2014 Mar; 37(3):332-9. PubMed ID: 23856968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
